Recent Advances towards the Treatment of Depressive Disorders.

Abstract:

:

journal_name

Curr Pharm Des

authors

Li K,Wang X

doi

10.2174/138161282422181019144120

subject

Has Abstract

pub_date

2018-01-01 00:00:00

pages

2513-2514

issue

22

eissn

1381-6128

issn

1873-4286

pii

CPD-EPUB-93845

journal_volume

24

pub_type

社论
  • Choice of Perioperative Anesthetic Medications in Patients Undergoing Bariatric Surgery.

    abstract::The prevalence of obesity is increasing globally. Rational perioperative anesthetic drug selection and administration require knowledge of how obesity interacts with those drugs. In this review, we summarize different aspects of the anesthetic agents, including pharmacokinetics (PK), pharmacodynamics (PD) and clinical...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612825666190628161206

    authors: Dos Reis Falcão LF,Mc Loughlin S,Alvarez A

    更新日期:2019-01-01 00:00:00

  • HPV pathway profiling: HPV related cervical dysplasia and carcinoma studies.

    abstract::Cervical cancer is the second most common malignancy among women worldwide. While more than 90% of cervical cancers carry one or more high risk HPV types, the exact relationship between HPV oncoproteins and signaling pathways alterations in cervical cancer remains to be clarified. Vaccines and targeted therapies are t...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161213804805577

    authors: Scholl SM,Kamal M,De Koning L,Kereszt A,Jordanova ES,Ungureanu S,Berns E,Sastre X

    更新日期:2013-01-01 00:00:00

  • Particle design of membrane emulsification for protein drug and vaccine delivery.

    abstract::Biodegradable particles have important applications in Drug Delivery Systems (DDS) of protein/peptide drugs. And recently, particle systems have also showed to be powerful for vaccine delivery (adjuvant) in order to solve the difficulties when conventional Alum adjuvant was used. However, in above applications, the pr...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612821666150416100031

    authors: Wang L,Yang T,Ma G

    更新日期:2015-01-01 00:00:00

  • Age-Appropriate Formulations Including Pharmaceutical Excipients in Neonatal Medicines.

    abstract:BACKGROUND:The development of appropriate pharmaceutical formulations for routine neonatal practice is challenging because of the developmental characteristics and the need for it to be specifically ageappropriate. This has led to wide use of extemporaneous formulations, which lack standardized procedures that can resu...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612823666170926122613

    authors: Kogermann K,Lass J,Nellis G,Metsvaht T,Lutsar I

    更新日期:2017-01-01 00:00:00

  • Regulation of angiogenesis and bone regeneration with natural and synthetic small molecules.

    abstract::Regeneration of bone requires the coordinated processes of angiogenesis and osteogenesis. These repair mechanisms are closely linked through both direct cell-cell contact and indirect paracrine signaling among osteoblasts, endothelial cells, and other cell types. The vasculature provides a source of nutrients, oxygen,...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612811319190007

    authors: Segar CE,Ogle ME,Botchwey EA

    更新日期:2013-01-01 00:00:00

  • Edible Mushrooms: Novel Medicinal Agents to Combat Metabolic Syndrome and Associated Diseases.

    abstract::Metabolic syndrome is an aggregation of conditions and associated with an increased risk of developing diabetes, obesity and cardiovascular diseases (CVD). Edible mushrooms are widely consumed in many countries and are valuable components of the diet because of their attractive taste, aroma, and nutritional value. Med...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612826666200831151316

    authors: Tung YT,Pan CH,Chien YW,Huang HY

    更新日期:2020-01-01 00:00:00

  • A Peptide Construct Mediates Focal Adhesion Pathway Through the Activation of Integrin Receptor.

    abstract:BACKGROUND:The integrin family receptors stimulate the cellular proliferation and migration through the focal adhesion pathway by the activation of PTK2, VASP and TSP1 proteins. The purpose of this study was to investigate the integrin-ligated motifs through the activation of focal adhesion pathway. METHODS:A chimeric...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612826666200311125325

    authors: Khosravi M,Kakavandi N,Rezaee S,Shabani M,Najafi M

    更新日期:2020-01-01 00:00:00

  • Tissue engineering techniques in cardiac repair and disease modelling.

    abstract::Cell therapy has been proposed to treat patients with end-stage heart failure. However, it has been suggested that the significant mechanical forces in an often ischaemic, inflamed, biochemically hostile environment may cause poor cell survival and retention. It is hypothesised that tissue engineering techniques could...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/13816128113199990442

    authors: Rao C,Barratt H,Prodromakis T,Terracciano CM

    更新日期:2014-01-01 00:00:00

  • The role of niacin in lipid-lowering treatment: are we aiming too high?

    abstract::The clinically most relevant medications for lipid management are the statins, which constitute in the majority of the cases the basis of any lipid-modulating therapy. However, other agents are often needed to either reduce low-density cholesterol to target levels and/or to treat residual serum lipoprotein abnormaliti...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612811319170017

    authors: Gouni-Berthold I,Berthold HK

    更新日期:2013-01-01 00:00:00

  • Current and future clinical strategies in colon cancer prevention and the emerging role of chemoprevention.

    abstract::In the third millennium preventive medicine is becoming a corner stone in our concept of health. Colorectal cancer (CRC) fits the criteria of a disease suitable for prevention interventions. It is a prevalent disease that is associated with considerable mortality and morbidity rates, with more than 1,000,000 new cases...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161207781368783

    authors: Boursi B,Arber N

    更新日期:2007-01-01 00:00:00

  • Leptin, immune responses and autoimmune disease. Perspectives on the use of leptin antagonists.

    abstract::The pivotal role of leptin in regulating body weight and energy homeostasis is very well established. More recently, leptin also emerged as an important regulator of T-cell-dependent immunity. Reduced leptin levels, as observed during periods of starvation, correlate with an impaired cellular immune response, whereby ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612053382070

    authors: Peelman F,Iserentant H,Eyckerman S,Zabeau L,Tavernier J

    更新日期:2005-01-01 00:00:00

  • Pharmacological Treatments for Fragile X Syndrome Based on Synaptic Dysfunction.

    abstract:BACKGROUND:Fragile X syndrome (FXS) is the most common form of monogenic hereditary cognitive impairment, including intellectual disability, autism, hyperactivity, and epilepsy. METHODS:This article reviews the literature pertaining to the role of synaptic dysfunction in FXS. RESULTS:In FXS, synaptic dysfunction alte...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612825666191102165206

    authors: Telias M

    更新日期:2019-01-01 00:00:00

  • Recent progress in work on PGD2 antagonists for drugs targeting allergic diseases.

    abstract::Prostaglandin (PG) D(2), the major cyclooxygenase metabolite generated from immunologically stimulated mast cells, is thought to contribute to the pathogenesis of allergic diseases due to its various inflammatory effects. However, the lack of PGD(2) (DP) receptor antagonists has limited the study of its essential role...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612043382864

    authors: Mitsumori S

    更新日期:2004-01-01 00:00:00

  • Modulation of cell death in age-related diseases.

    abstract::Aging is a stage of life of all living organisms. According to the free-radical theory, aging cells gradually become unable to maintain cellular homeostasis due to the adverse effects of reactive oxygen species (ROS). ROS can cause irreversible DNA mutations, protein and lipid damage which are increasingly accumulated...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/13816128113196660702

    authors: Tezil T,Basaga H

    更新日期:2014-01-01 00:00:00

  • Exercise addiction- diagnosis, bio-psychological mechanisms and treatment issues.

    abstract::Exercise and sports activity are beneficial both physically and psychologically but excessive exercise may have adverse physiological and psychological effects. There are methodological issues in the definition, diagnosis and etiology of exercise addiction. Several questionnaires and diagnostic tools have been develop...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/13816128113199990614

    authors: Weinstein A,Weinstein Y

    更新日期:2014-01-01 00:00:00

  • Clopidogrel, aspirin and proton pump inhibition after percutaneous valve implants: an update.

    abstract:OBJECTIVES:This paper reviews literary evidence on antithrombotic therapies currently employed in TAVR to assess validity and efficacy; duration and modality are also considered. In the absence of firm guidelines and reliable trial results, we analyze current knowledge of interaction between PPI and antithrombotic drug...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612811319220002

    authors: Fusari M

    更新日期:2013-01-01 00:00:00

  • Potential novel anxiolytic drugs.

    abstract::Anxiety disorders are common and disabling conditions. Current drug treatment methods have limitations including resistance, delayed efficacy and side effects. The advent of sophisticated imaging techniques and the production of highly selective receptor ligands have increased our knowledge of the biological mechanism...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161208786848775

    authors: Christmas D,Hood S,Nutt D

    更新日期:2008-01-01 00:00:00

  • Nanofibers based tissue engineering and drug delivery approaches for myocardial regeneration.

    abstract::Human heart has endogenous regenerative capability; however, the intrinsic repair mechanism is not sufficient to overcome the impact placed by adverse pathological conditions, such as myocardial infarction (MI). In such circumstances, the damaged tissue initiates a series of remodeling process which results in the det...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612821666150302153138

    authors: Joshi J,Kothapalli CR

    更新日期:2015-01-01 00:00:00

  • Recent development and application of virtual screening in drug discovery: an overview.

    abstract::Virtual screening, especially the structure-based virtual screening, has emerged as a reliable, cost-effective and time-saving technique for the discovery of lead compounds. Here, the basic ideas and computational tools for virtual screening have been briefly introduced, and emphasis is placed on aspects of recent dev...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612043452721

    authors: Hou T,Xu X

    更新日期:2004-01-01 00:00:00

  • An Updated Review of Disulfiram: Molecular Targets and Strategies for Cancer Treatment.

    abstract::Repurposing already approved drugs as new anticancer agents is a promising strategy considering the advantages such as low costs, low risks and less time-consumption. Disulfiram (DSF), as the first drug for antialcoholism, was approved by the U.S. Food and Drug Administration (FDA) over 60 years ago. Increasing eviden...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612825666190816233755

    authors: Yang Q,Yao Y,Li K,Jiao L,Zhu J,Ni C,Li M,Dou QP,Yang H

    更新日期:2019-01-01 00:00:00

  • Radiolabeled compounds in diagnosis of infectious and inflammatory disease.

    abstract::Nuclear medicine offers powerful noninvasive techniques for visualization of infectious and inflammatory disorders using whole body imaging enabling the determination of both localization and number of inflammatory foci. A wide variety of approaches depicting the different stages of the inflammatory response have been...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612043383539

    authors: Bleeker-Rovers CP,Boerman OC,Rennen HJ,Corstens FH,Oyen WJ

    更新日期:2004-01-01 00:00:00

  • Drug delivery system of anti-fungal and parasitic agents.

    abstract::The antifungal agents for systemic mycoses are only a few in number. Among them amphotericin-B is still the most widely used drug, but substantial side effects including nephrotoxicity limits its clinical usefulness. Efforts to lower the toxicity are synthesis of AMPH-B analogues such as AMPH-B esters and encapsulatio...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612023395916

    authors: Maesaki S

    更新日期:2002-01-01 00:00:00

  • Perioperative Management of DOACs in Vascular Surgery: A Practical Approach.

    abstract:BACKGROUND:Approximately 10-15% of patients on DOACs have to interrupt their anticoagulant before an invasive procedure every year. The perioperative management and monitoring of DOACs have proved to be challenging, as differences in patients' status and in the invasiveness of each procedure develop different situation...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612825666181226154746

    authors: Kouvelos G,Matsagkas M,Rousas N,Nana P,Mpatzalexis K,Stamoulis K,Giannoukas A,Arnaoutoglou E

    更新日期:2018-01-01 00:00:00

  • Angiotensin (1-7) and other angiotensin peptides.

    abstract::In the classical renin angiotensin system (RAS), angiotensin II Ang IIplays many important roles in cardiovascular disease and in kidney, brain, and other organs via the Ang II type 1 receptor (AT1). The RAS consists of many angiotensin peptides, including Ang (1-7), Ang (1-9), Ang (2-8), and Ang IV. Ang (1-7), produc...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612811319170013

    authors: Ohishi M,Yamamoto K,Rakugi H

    更新日期:2013-01-01 00:00:00

  • Inhibitors of HIV-1 entry.

    abstract::Since the discovery of human immunodeficiency virus (HIV) as a causative agent of acquired immune deficiency syndrome (AIDS) various strategies were employed to counter its devastating actions. One such concept relies on the prevention of HIV entry into host's "competent" cells by means of compounds known as entry inh...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612811319100003

    authors: Micewicz ED,Ruchala P

    更新日期:2013-01-01 00:00:00

  • Enkephalin degrading enzymes: metalloproteases with high potential for drug development.

    abstract::Enkephalins play a great role in management of pain, blood pressure, hypertension and cardiovascular diseases. Enkephalins are short-lived molecules being rapidly hydrolyzed following their synaptic release by enkephalin degrading enzymes. The inhibitors of enkephalin degrading enzymes are able to prolong the duration...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161212799040547

    authors: Khaket TP,Singh J,Attri P,Dhanda S

    更新日期:2012-01-01 00:00:00

  • Metallothionein: A Novel Therapeutic Target for Treatment of Inflammatory Bowel Disease.

    abstract::Inflammatory bowel disease (IBD) is a group of disorders characterized by chronic inflammation within the gastrointestinal tract. It is a multifactorial disease associated with immune-cell mediated oxidative damage to the intestinal mucosa. There is no cure for IBD, but anti-cytokine therapy can limit target inflammat...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612824666180717110236

    authors: Dostie KE,Thees AV,Lynes MA

    更新日期:2018-01-01 00:00:00

  • Glucose metabolism and insulin resistance in sepsis.

    abstract::Hyperglycemia is a common feature of the critically ill in general and of patients with sepsis in particular. Even a moderate degree of hyperglycemia appears detrimental for the outcome of critically ill patients, since maintenance of normoglycemia (blood glucose levels

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161208784980563

    authors: Van Cromphaut SJ,Vanhorebeek I,Van den Berghe G

    更新日期:2008-01-01 00:00:00

  • Ras signaling pathway proteins as therapeutic targets.

    abstract::Ras is a 21 kDa membrane-localized G protein that is coupled to receptor and non-receptor tyrosine kinase activation of downstream cytoplasmic and nuclear events. Mutated ras genes are common, and occur in a wide variety of human malignancies. These activating mutations result in constitutive signaling, thereby stimul...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612013397258

    authors: Adjei AA

    更新日期:2001-11-01 00:00:00

  • Raloxifene and cardiovascular health: its relationship to lipid and glucose metabolism, hemostatic and inflammation factors and cardiovascular function in postmenopausal women.

    abstract::CHD is one of the most common serious chronic conditions in postmenopausal women and leads to extremely high risk for recurrent myocardial infarction and death. On the basis of the currently available randomized clinical-trial results the role of conventional HRT for treatment and prevention of CHD is rapidly evolving...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161205774913237

    authors: Francucci CM,Camilletti A,Boscaro M

    更新日期:2005-01-01 00:00:00